Overview
No overview information available.
Background
No background information available.
Indication
用于血栓闭塞性脉管炎及其他闭塞性血管疾病和冠心病的辅助治疗。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/07/18 | Not Applicable | Not yet recruiting | First People's Hospital of Shenyang | ||
2024/03/25 | Phase 4 | Recruiting |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Daphnetin Capsules | 国药准字H22025737 | 化学药品 | 胶囊剂 | 4/8/2020 | |
| Daphnetin Capsules | 国药准字H22024495 | 化学药品 | 胶囊剂 | 4/8/2020 | |
| Daphnetin Capsules | 国药准字H22024043 | 化学药品 | 胶囊剂 | 3/17/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||